Search Ontology:
ChEBI

AZ505

Term ID
CHEBI:228259
Synonyms
  • AZ 505
  • AZ-505
  • N-cyclohexyl-3-[2-(3,4-dichlorophenyl)ethylamino]-N-[2-[2-(5-hydroxy-3-oxo-4H-1,4-benzoxazin-8-yl)ethylamino]ethyl]propanamide
  • N-cyclohexyl-N(3)-[2-(3,4-dichlorophenyl)ethyl]-N-(2-{[2-(5-hydroxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-8-yl)ethyl]amino}ethyl)-beta-alaninamide
Definition
A benzoxazine that is 2H-1,4-benzoxazin-3(4H)-one substituted by a hydroxy group at position 5 and a 2-{[2-(cyclohexyl{N-[2-(3,4-dichlorophenyl)ethyl]-β-alanyl}amino)ethyl]amino}ethyl group at position 8. It is a potent and selective inhibitor of SMYD2.
References
  • cas:1035227-43-0
  • pubmed:21782458
  • pubmed:25834495
  • pubmed:28588028
  • pubmed:28604386
  • pubmed:29487338
  • pubmed:31754403
  • pubmed:32277055
  • pubmed:33935284
  • pubmed:34143514
  • pubmed:34510321
  • pubmed:34905676
  • pubmed:35455942
  • pubmed:35759739
  • pubmed:35939202
  • pubmed:36046818
  • pubmed:37036190
  • pubmed:37315132
  • pubmed:37524453
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from AZ505
Phenotype where environments contain AZ505
Phenotype modified by environments containing AZ505
Phenotype affecting AZ505
Human Disease Model